Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Daiichi Sankyo
Boehringer Ingelheim
Harvard Business School
Queensland Health
US Department of Justice
US Army
Johnson and Johnson
Teva

Generated: July 15, 2018

DrugPatentWatch Database Preview

AXID Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Axid, and what generic alternatives are available?

Axid is a drug marketed by Smithkline Beecham, Braintree, and Pfizer. and is included in three NDAs. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has two patent family members in two countries.

The generic ingredient in AXID is nizatidine. There are seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the nizatidine profile page.
Drug patent expirations by year for AXID
Medical Subject Heading (MeSH) Categories for AXID
Synonyms for AXID
(E)-1-N'-[2-[[2-(dimethylaminomethyl)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
(E)-N-(2-(((2-((dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N'-methyl-2-nitroethene-1,1-diamine
(E)-N-[2-[[2-(dimethylaminomethyl)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-N'-methyl-2-nitroethene-1,1-diamine
(E)-N-{2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)thio]ethyl}-N'-methyl-2-nitroethene-1,1-diamine
(E)-N1'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine
(E)-N1'-[2-[[2-[(dimethylamino)methyl]-4-thiazolyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine
[(E)-1-({2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)sulfanyl]ethyl}amino)-2-nitroethenyl](methyl)amine
1,1-Ethenediamine, N-(2-(((2-((dimethylamino)methyl)-4-thiazoly)methyl)thio)ethyl)-N'-methyl-2-nitro-
1,1-Ethenediamine, N-(2-(((2-((dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-
1,1-ethenediamine, n-[2-[[[2-[(dimethylamino)methyl]-4-thiazolyl]methyl]thio]ethyl]-n'-methyl-2-nitro-
1,1-Ethenediamine, N'-[2-[[[2-[(dimethylamino)methyl]-4-thiazolyl]methyl]thio]ethyl]-N-methyl-2-nitro-
76963-41-2
963N412
A838919
AB00698253_09
AB00698253-07
AB0106214
AB2000352
AC-5272
AC1MHW19
AC1Q1WQW
AC1Q40UA
Acinon
Acinon (TN)
AKOS015900643
Ambap76963-41-2
Antizid
Axid (TN)
Axid Ar
BIDD:GT0761
BRD-K92193792-001-01-7
BRN 4846056
C07270
C12H21N5O2S2
Calmaxid
CAS-76963-41-2
CCG-100836
CHEBI:7601
CHEMBL653
CPD000466384
Cronizat
CS-2350
D00440
D0Q9DK
DB00585
dimethyl[(4-{[(2-{[(E)-1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}-1,3-thiazol-2-yl)methyl]amine
dimethyl[(4-{[(2-{[1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}-1,3-thiazol-2-yl)methyl]amine
Distaxid
EBD34008
Galitidin
Gastrax
GTPL7248
HE004790
HE337554
HE387409
HMS2051K04
HMS2094A15
HMS2235N05
HS-0083
HSDB 3574
HY-B0310
I14-0503
L000761
LS-67650
LY 139037
LY-139037
LY-139037, Nizatidine
MLS000759518
MLS001076680
MLS001424001
MolPort-003-849-605
MolPort-027-655-252
N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine
N-(4-(6-Methylamino-7-nitro-2-thia-5-aza-6-hepten-1-yl)-2-thiazolylmethyl)-N,N-dimethylamin
N-(4-(6-Methylamino-7-nitro-2-thia-5-aza-6-hepten-1-yl)-2-thiazolylmethyl)-N,N-dimethylamine
N-{2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine
Naxidine
NC00086
NCGC00016934-01
NCGC00016934-02
NE47126
Niatidine
Niaztidine
Nizatidina
Nizatidina [Spanish]
nizatidine
Nizatidine (JAN/USP/INN)
Nizatidine (JP17/USP/INN)
Nizatidine [USAN:BAN:INN:JAN]
Nizatidine-d3
Nizatidine, analytical standard
Nizatidinum
Nizatidinum [Latin]
Nizax
Nizaxid
NSC-759289
NSC759289
Panaxid
Pharmakon1600-01505985
Prestwick2_000921
SAM001246752
SBI-0206937.P001
SC-15260
SCHEMBL769
SCHEMBL770
SGXXNSQHWDMGGP-IZZDOVSWSA-N
SMR000466384
Splendil ER
Tazac
Tazac (TN)
Tazac;Axid;Axid AR
Ulcosol
Ulxid
Zanizal
ZE-101
ZINC1530736
Zinga
ZL-101

US Patents and Regulatory Information for AXID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-001 Apr 12, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer AXID AR nizatidine TABLET;ORAL 020555-001 May 9, 1996 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-002 Apr 12, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Braintree AXID nizatidine SOLUTION;ORAL 021494-001 May 25, 2004 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for AXID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-002 Apr 12, 1988 ➤ Sign Up ➤ Sign Up
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-001 Apr 12, 1988 ➤ Sign Up ➤ Sign Up
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-002 Apr 12, 1988 ➤ Sign Up ➤ Sign Up
Smithkline Beecham AXID nizatidine CAPSULE;ORAL 019508-001 Apr 12, 1988 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for AXID
Drugname Dosage Strength RLD Date
➤ Subscribe Oral Solution 15 mg/mL ➤ Subscribe ➤ Sign Up

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Fish and Richardson
Argus Health
McKinsey
Deloitte
Express Scripts
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.